Quick DetailS:
Product description:
Origin of the Active Ingredient: KIGTROPIN is a Recombinants Human Growth Hormone. KIGTROPIN is produced by recombinant DNA technology in E.coli secretion expression system. KIGTROPIN has the same amino acid sequence with 191 residues as the native human growth hormone produced in the human body
Before administration, add 1ml of sterile water for injection to the rhGH vial of Lyophilized powder along the wall slowly. Shake it gently to fully dissolve the powder to get clarified solution. DO NOT shake violently.
The recommended dosage for injection is 0.1-0.15IU/kg/day, inject before sleeping daily at the same time and the injection site should be changes frequently to prevent lipoatrophy at the site, or follow the physician's advice.
Applications:
For gaining lean muscle and substantially improving body composition, a dose of 4-8 IUs per day will be necessary. Most people will respond very well at a dose of 4-5 IU's per day. For maximum benefit in this regard, the addition of Testosterone, Insulin, and low-dose t3 would be something to seriously consider. More on this in our comparative cycle guide of HGH/Insulin/IGF.
Adverse reaction:Growth hormone may induce transient hyperglycosemia, which usually recover to normal level over time or after drug discontinuation.About 1% children with microsomia in the clinical trial presented side effects, which usually presented transient reactions at the injection site (pain, tingling numbness, red swelling, etc) and the symptoms of fluid retention (peripheral edema, arthralgia or myalgia).These side effects usually appear at early stage and the incidence rate decreases over time which rarely affects daily activities.
Long-term injection of recombinant human growth hormone results in antibody production in minority people, however, the affinity of the antibody is low without exact clinical significance, The antibody may be induced if the anticipant effect of growth is not achieved, which may affect the efficacy if the affinity is over 2 mg/L.
COA:
Items | Standard | Test Results |
[Description] | colorless, clear and transparent solution | Conformed |
Identification | ||
Mobility | In conformity with Standard | In conformity with Standard |
Related Proteins | In conformity with Standard | In conformity with Standard |
Peptide Mapping | In conformity with Standard | In conformity with Standard |
Test | ||
PH | 6.5-8.0 | 7.2 |
Related Proteins | No more then 8.0% | 1.76% |
High Molecular Weight Protein | No more then 3.0% | 0.6% |
SDS-PAGE purity | Scanning not less than 95.0% | 99.2% |
Bacterial endotoxins: | No more then 5EU/mg | <4.0EU/mg |
E.coli DNA Residue | No more then 10ng/mg | <10ng/mg |
Host-cell-derived proteins | No more then 15ng/mg | 8ng/mg |
Assay | ———— | 17.42mg/ml |
Conclusion |
Fulfill with Pharmacopoeia of the People's Republic
of China(2005 Volume ) Specifications |
|
Remarks |
RP-HPLC purity >93%;
Content of the monomer:SDS-PAGE>99%,HPLC>98% Amino aicid assay: 191 AA |
Packaging & Delivery: